A case–control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (10) , 1475-1477
- https://doi.org/10.1097/00002030-200007070-00034
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- CD4 cell counts at the third month of HAART may predict clinical failureAIDS, 1999
- Outcome and Predictors of Failure of Highly Active Antiretroviral Therapy: One‐Year Follow‐Up of a Cohort of Human Immunodeficiency Virus Type 1–Infected PersonsThe Journal of Infectious Diseases, 1999
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapyAIDS, 1999
- HIV and the Older AdultJournal of Gerontological Nursing, 1998
- Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infectionAIDS, 1998
- Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patientsAIDS, 1998
- Survival for Women and Men with AIDSThe Journal of Infectious Diseases, 1992
- A Literature Review: HIV SEROPOSITIVITY IN THE ELDERLYJournal of Gerontological Nursing, 1991
- Survival Patterns of the First 500 Patients with AIDS in San FranciscoThe Journal of Infectious Diseases, 1988